Neuronal nicotinic receptors in synaptic functions in humans and rats: Physiological and clinical relevance

Behavioural Brain Research

Volumn 113, Issue 1-2, 2000, Pages 131-141

  Albuquerque, Edson X ^a,b   Pereira, Edna F R ^a   Mike, Arpad ^a   Eisenberg, Howard M ^a   Maelicke, Alfred ^c   Alkondon, Manickavasagom ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Inst Physiologische Chem P   (Germany)

Author keywords

Acetylcholine; Cerebral cortex; Choline; Electrophysiology; GABA; Hippocampus; Human; Slices

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINE; CHOLINE; DIHYDRO BETA ERYTHROIDINE; LIDOCAINE ETHOBROMIDE; METHYLLYCACONITINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DESENSITIZATION; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INTERNEURON; NERVE CELL; NERVE CELL STIMULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; CULTURE TECHNIQUES; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMANS; INTERNEURONS; MEMBRANE POTENTIALS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 0033841631     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00208-4     Document Type: Article

References (90)

1. Albuquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280:1997;1117-1136.
2. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1473.
3. Alkondon M., Albuquerque E.X. Diversity of nicotinic receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J. Pharmacol. Exp. Ther. 274:1995;771-782.
4. Alkondon M., Pereira E.F.R., Albuquerque E.X. α-Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res. 810:1998;257-263.
5. Alkondon M., Pereira E.F.R., Barbosa C.T.F., Albuquerque E.X. Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283:1997;1396-1411.
6. Alkondon M., Pereira E.F.R., Cortes W.S., Maelicke A., Albuquerque E.X. Choline is a selective agonist of α7 nicotinic acetylcholine receptors in rat brain neurons. Eur. J. Neurosci. 9:1997;2734-2742.
7. Alkondon M., Pereira E.F.R., Eisenberg H.M., Albuquerque E.X. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J. Neurosci. 19:1999;2693-2705.
8. Alkondon M., Pereira E.F.R., Eisenberg H.M., Albuquerque E.X. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. J. Neurosci. 20:2000;66-75.
9. Alkondon M., Reinhardt-Maelicke S., Lobron C., Hermsen B., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: II. rundown and inward rectification of agonist-elicited whole-cell currents and in situ hybridization studies. J. Pharmacol. Exp. Ther. 371:1994;494-506.
10. Balfour D.J.K. Neural mechanisms underlying nicotine dependence. Addiction. 89:1994;1419-1423.
11. Ben-Shlomo Y. The epidemiology of Parkinson's disease. Ballieres Clin. Neurol. 6:1997;55-68.
12. Bertolino M., Kellar K.J., Vicini S., Gillis R.A. Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus. Neuroscience. 79:1997;671-681.
13. Castro N.G., Albuquerque E.X. Brief-lifetime, fast-inactivating ion channels account for the α-bungarotoxin-sensitive nicotinic response in hippocampal neurons. Neurosci. Lett. 164:1993;137-140.
14. Changeux J.P., Bertrand D., Corringer P.J., Dehaene S., Edelstein S., Léna C., Le Novère N., Marubio L., Picciotto M., Zoli M. Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res. Brain Res. Rev. 26:1998;198-216.
15. Clarke P.B.S. Functional anatomy of nicotinic acetylcholine receptors in mammalian brain. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1999;127-139 Wiley, New York.
16. Dagli E. Are low income countries targets of the tobacco industry? Int. J. Tuberc. Lung Dis. 3:1990;113-118.
17. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am. J. Psychiatry. 155:1998;1490-1501.
18. Daudt A.W., Alberg A.J., Prola J.C., Fialho L., Petracco A., Wilhelms A., Weiss A., Estery C. A first step incorporating smoking education into a Brazilian medical school curriculum: results of a survey to assess the cigarette smoking knowledge, attitudes, behaviour, and clinical practices of medical students. Addict. Dis. 18:1999;19-29.
19. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56:1995;545-570.
20. Dempster J. Computer analysis of electrophysiological signals. Frazer P.J. Microcomputers in Physiology: A Practical Approach. 1989;51-93 IRI, Oxford.
21. Dewey S.L., Brodie J.D., Gerasimov M., Horan B., Gardner E.L., Ashby C.R. Jr A pharmacologic strategy for the treatment of nicotine addiction. Synapse. 31:1999;76-86.
22. Djordjevic M.V., Hoffmann D., Hoffmann I. Nicotine regulates smoking patterns. Prev. Med. 26:1997;435-440.
23. Elmslie F.V., Rees M., Williamson M.P., Kerr M., Kjeldsen M.J., Pang K.A., Sundqvist A., Friis M.L., Chadwick D., Richens A., Covanis A., Santos M., Arzimanoglou A., Panayiotopoulos C.P., Curtis D., Whitehouse W.P., Gardiner R.M. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum. Mol. Genet. 6:1997;1329-1334.
24. Epping Jordan M.P., Watkins S.S., Koob G.F., Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 393:1998;76-79.
25. Faue M., Folen R.A., James L.C., Needels T. The Tripler Tobacco-Cessation Program: predictors for success and improved efficacy. Mil. Med. 162:1997;445-449.
26. Ferraro L., Tanganelli S., Caló G., Antonelli T., Fabrizi A., Acciarri N., Bianchi C., Beani L., Simonato M. Noradrenergic modulation of gamma-aminobutyric acid outflow from the human cerebral cortex. Brain Res. 629:1993;103-108.
27. Fisher J.L., Pidoplichko V.I., Dani J.A. Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons. J. Physiol. (Paris). 92:1998;209-213.
28. Flores C.M., Hargreaves K.M. Neuronal nicotinic receptors: new targets in the treatment of pain. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1999;359-377 Wiley, New York.
29. Frazier C.J., Buhler A.V., Weiner J.L., Dunwiddie T.V. Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci. 18:1998;8228-8235.
30. Frazier C.J., Rollins Y.D., Breese C.R., Leonard S., Freedman R., Dunwiddie T.V. Acetylcholine activates an α-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J. Neurosci. 18:1998;1187-1195.
31. Freedman R., Coon H., Myles Worsley M., Orr Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA. 94:1997;587-592.
32. Galzi J.L., Changeux J.-P. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology. 34:1995;563-582.
33. Galzin A.M., Poirier M.F., Lista A., Chodkiewicz J.P., Blier P., Ramdine R., Loô H., Roux F.X., Redondo A., Langer S.Z. Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex. J. Neurochem. 59:1992;1293-1301.
34. Gerlach M., Gsell W., Kornhuber J., Jellinger K., Krieger V., Pantucek F., Vock R., Riederer P. A post mortem study on neurochemical markers of dopaminergic, GABAergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res. 741:1996;142-152.
35. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog. Neurobiol. 53:1997;199-237.
36. Gray R., Rajan A.S., Radcliffe K.A., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 389:1996;713-716.
37. Hagan J.J., Middlemiss D.N., Sharpe P.C., Poste G.H. Parkinson's disease: prospects for improved drug therapy. Trends Pharmacol. Sci. 18:1997;156-163.
38. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 39:1981;85-100.
39. Henningfield J.E., Fant R.V., Tomar S.L. Smokeless tobacco: an addicting drug. Adv. Dent. Res. 11:1997;330-335.
40. Hietala J., Syvälahti E. Dopamine in schizophrenia. Ann. Med. 28:1996;557-561.
41. Hill C. Trends in tobacco smoking and consequences on health in France. Prev. Med. 27:1998;514-519.
42. Hilmas C., Alkondon M., Eisenberg H.M., Albuquerque E.X. Nicotinic receptor activation modulates GABA release from neurons in human cortical slices. Abstr. Soc. Neurosci. 24:1998;1581.
43. Ikemoto S., Kohl R.R., McBride W.J. GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J. Neurochem. 69:1997;137-143.
44. Jones S., Yakel J.L. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J. Physiol. (Lond.). 504:1997;603-610.
45. Kandel E.R., Schwartz J.H. Directly gated transmission at central synapses. Kandel E.R., Schwartz J.H., Jessel T.M. Principles of Neural Science. 3rd ed. 1991;153-172 Appleton and Lange, East Norwalk, CT.
46. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J. Neurosci. 17:1997;9035-9047.
47. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J. Neurosci. 17:1997;576-585.
48. Léna C., Changeux J.-P., Mulle C. Evidence for 'preterminal' nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13:1993;2680-2688.
49. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22:1996;431-445.
50. Levin E.D., Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl.). 138:1998;217-330.
51. Lindstrom J. Nicotinic acetylcholine receptors. North A.R. Ligand- and Voltage-Gated Ion Channels. 1995;153-175 CRC Press, Boca Raton, FL.
52. Lindstrom J., Anand R., Gerzanich V., Peng X., Wang F., Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 109:1996;125-137.
53. Lloyd G.K., Menzaghi F., Bontempi B., Suto C., Siegel R., Akong M., Stauderman K., Velicelebi G., Johnson E., Harpold M.M., Rao T.S., Sacaan A.I., Chavez Noriega L.E., Washburn M.S., Vernier J.M., Cosford N.D., McDonald L.A. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci. 62:1998;1601-1606.
54. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.-P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
55. Mackay J. The global tobacco epidemic. The next 25 years. Public Health. 113:1998;14-21.
56. Mangan G.L., Golding J.F. The effects of smoking on memory consolidation. J. Psychol. 115:1983;65-77.
57. Marubio L.M., del Mar Arroyo Jimenez M., Cordero Erausquin M., Léna C., Le Novère N., de Kerchove dExaerde A., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810.
58. McMahon L.L., Yoon K.W., Chiappinelli V.A. Nicotinic receptor activation facilitates GABAergic neurotransmission in the avian lateral spiriform nucleus. Neuroscience. 59:1994;689-698.
59. Mike A, Albuquerque EX. A kinetic analysis of acetylcholine- and choline-activated α7-containing nicotinic receptor channels in hippocampal neurons. Proc. Mtg. Neuronal Nicotinic Receptors, Venice, Italy, 1999:69.
60. Miyake A., Mochizuki S., Takemoto Y., Akuzawa S. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol. Pharmacol. 48:1995;407-416.
61. Morens D.M., Grandinetti A., Davis J.W., Ross G.W., White L.R., Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am. J. Epidemiol. 144:1996;400-404.
62. Mui W.C., Zbuzek V.K., Wu W.H. GABA(A) antagonist and nicotine-induced antinociception. Life Sci. 61:1997;221-225.
63. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 349:1997;1498-1504.
64. Newhouse P.A., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging. 11:1996;206-228.
65. A receptor binding in human brain by neuroactive steroids: species and brain regional differences. Synapse. 19:1995;77-87.
66. Papke R.L., Bencheriff M., Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptors activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype. Neurosci. Lett. 213:1996;201-204.
67. Parkin C., Fairweather D.B., Shamsi Z., Stanley N., Hindmarch I. The effects of cigarette smoking on overnight performance. Psychopharmacology (Berl.). 136:1998;172-178.
68. Peeke S.C., Peeke H.V. Attention, memory, and cigarette smoking. Psychopharmacology (Berl.). 84:1984;205-216.
69. Pereira E.F.R., Alkondon M., McIntosh J.M., Albuquerque E.X. α-Conotoxin-ImI, a competitive nicotinic antagonist at α-bungarotoxin-sensitive neuronal nicotinic receptors. J. Pharmacol. Exp. Ther. 278:1996;1472-1483.
70. Pereira E.F.R., Barbosa C.T.F., Alkondon M., Rocha E.S., Albuquerque E.X., Eisenberg H.M. Ligand-gated ion channels on human neurons. Abstr. Soc. Neurosci. 23:1997;374.
71. Picciotto M.R. Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend. 51:1998;165-172.
72. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer. 83:1999;18-29.
73. Radcliffe K.A., Dani J.A. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J. Neurosci. 18:1998;7075-7083.
74. Roerig B., Nelson D.A., Katz L.C. Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J. Neurosci. 17:1997;8353-8362.
75. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
76. Shiffman S., Mason K.M., Henningfield J.E. Tobacco dependence treatments: review and prospectus. Annu. Rev. Public Health. 19:1998;335-358.
77. Stein E.A., Pankiewicz J., Harsch H.H., Cho J.K., Fuller S.A., Hoffmann R.G., Hawkins M., Rao S.M., Bandettini P.A., Bloom A.S. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am. J. Psychiatry. 155:1998;1009-1015.
78. Svoboda K.R., Adams C.E., Lupica C.R. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J. Neurosci. 19:1999;85-95.
79. Thompson G.H., Hunter D.A. Nicotine replacement therapy. Ann. Pharmacother. 32:1998;1067-1075.
80. van Kammen D.P., Petty F., Kelley M.E., Kramer G.L., Barry E.J., Yao J.K., Gurklis J.A., Peters J.L. GABA and brain abnormalities in schizophrenia. Psychiatry Res. 82:1998;25-35.
81. Volger B.W. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Clin. Pharm. 10:1991;447-456.
82. Weinberger D.R. The biological basis of schizophrenia: new directions. J. Clin. Psychiatry. 58:1997;22-27.
83. Wevers A., Monteggia L., Nowacki S., Bloch W., Schütz U., Lindstrom J., Pereira E.F.R., Eisenberg H., Giacobini E., deVos R.A.I., Jansen Steur S.E.N.H., Maelicke A., Albuquerque E.X., Schröder H. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease - histotopographical correlation with amyloid plaques and hyperphosphorylated tau-protein. Eur. J. Neurosci. 11:1999;2551-2565.
84. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38:1998;720-723.
85. Whitehouse P.J., Kalaria R.N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis. Assoc. Disord. 9:1995;3-5.
86. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
87. Xi Z.X., Stein E.A. Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors - an in vivo electrochemical study. Brain Res. 798:1998;156-165.
88. Zilles K., Schröder H., Schröder U., Horvath E., Werner L., Luiten P.G., Maelicke A., Strosberg A.D. Distribution of cholinergic receptors in the rat and human neocortex. EXS. 57:1989;212-228.
89. Zhang M., Wang Y.T., Vyas D.M., Neuman R.S., Bieger D. Nicotinic cholinoceptor-mediated excitatory postsynaptic potentials in rat nucleus ambiguus. Exp. Brain Res. 96:1993;83-88.
90. Zwart R., Vijverberg H.P.M. Co-agonist effects of choline on heteromeric neuronal nAChRs. Abstr. Soc. Neurosci. 25:1999;1242.